TNF‑α promotes insulin resistance in obstructive sleep apnea‑hypopnea syndrome

Zhao,Lin; Liu,Yang; Wang,Xiangrong

doi:10.3892/etm.2021.10000

TNF‑α promotes insulin resistance in obstructive sleep apnea‑hypopnea syndrome

Authors:
- Lin Zhao
- Yang Liu
- Xiangrong Wang
View Affiliations

Affiliations: Department of Endocrinology, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Beijing 100091, P.R. China, Department of Nursing, Jiangsu Union Technical Institute Nantong Health Branch, Nantong, Jiangsu 226010, P.R. China
Published online on: March 29, 2021 https://doi.org/10.3892/etm.2021.10000
Article Number: 568
Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Obstructive sleep apnea hypopnea syndrome (OSAHS) is the most serious among children with sleep disordered breathing. The present study aimed to investigate whether TNF‑α could decrease the glucose transporter type 4 insulin‑responsive (GLUT‑4) expression to promote insulin resistance through the TNF‑α/IKKβ/IKβ/NF‑κB signaling pathway in OSAHS. In total, 30 obese children with OSAHS and 30 non‑OSAHS obese children were enrolled into the present study. TNF‑α expression in adenoid tissues was detected by western blot analysis and immunohistochemistry. The expression of inflammatory factors (IL‑1β, IL‑6 and IFN‑γ) and TNF‑α/IKKβ/IKβ/NF‑κB signaling pathway‑associated proteins was also detected by western blot analysis. The expression of insulin resistance‑associated factors, insulin receptor substrate 1 (IRS1) and GLUT4, was determined by western blot analysis and immunohistochemistry. TNF‑α expression was increased in adenoid tissues of children with OSAHS, which was also confirmed by immunohistochemistry. The expression levels of IL‑1β, IL‑6 and IFN‑γ were all upregulated in adenoid tissues of children with OSAHS. The expression of IRS1 and GLUT4 was decreased in adenoid tissues of obese children with OSAHS and the result of immunohistochemistry was consistent with the result of western blot analysis. The protein level of TNF‑α, and ratio of phosphorylated (p‑)/total (t)‑IKKβ, p/t‑IKβ and p/t‑NF‑κB was increased in adenoid tissues of children with OSAHS. TNF‑α could suppress the GLUT4 expression to promote insulin resistance by TNF‑α/IKKβ/IKβ/NF‑κB signaling pathway in OSAHS.

View Figures

View References

1	De Backer W: Obstructive sleep apnea/hypopnea syndrome. Panminerva Med. 55:191–195. 2013.PubMed/NCBI
2	Shen L, Lin Z, Xu Y and Yang Z: The relationship between obstructive sleep apnea hypopnea syndrome and adenoid size as well as tonsil size in children. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 28:381–385. 2014.PubMed/NCBI(In Chinese).
3	Yu M: Relationship between obstructive sleep apnea hypopnea syndrome and obesity in children. J Clin Nurs. 18:58–60. 2019.
4	Chen J, Duo L and Ye H: Research progress on obstructive sleep apnea hypopnea syndrome and insulin resistance in children. Zhongguo Shiyong Erke Zazhi. 78–80. 2008.(In Chinese).
5	He L, Li S, Shi H and Feng Y: The clinical investigation of the relationship between obstructive sleep apnea-hypopnea syndrome and insulin resistance. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 21:353–355. 2007.PubMed/NCBI(In Chinese).
6	Chen Z: The research of the correlation of obstructive sleep apnea-hypopnea syndrome and insulin resistance. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 21:410–412. 2007.PubMed/NCBI(In Chinese).
7	Yang H, Yang Z-b, Zhu B, Zou Y and Tian T-j: Clinical study on the growth and development of children with mandibular retrusion and adenoid hypertrophy. J Clin Stomatol. 36:356–359. 2020.
8	Clemmons DR: Role of insulin-like growth factor iin maintaining normal glucose homeostasis. Horm Res. 62 (Suppl 1):77–82. 2004.PubMed/NCBI View Article : Google Scholar
9	Simpson HL, Jackson NC, Shojaee-Moradie F, Jones RH, Russell-Jones DL, Sönksen PH, Dunger DB and Umpleby AM: Insulin-like growth factor I has a direct effect on glucose and protein metabolism, but no effect on lipid metabolism in type 1 diabetes. J Clin Endocrinol Metab. 89:425–432. 2004.PubMed/NCBI View Article : Google Scholar
10	Borst SE: The role of TNF-alpha in insulin resistance. Endocrine. 23:177–182. 2004.PubMed/NCBI View Article : Google Scholar
11	Hotamisligil GS: Mechanisms of TNF-α-induced insulin resistance. Experimental and clinical endocrinology & diabetes: Official journal, German Society of Endocrinology. Ger Diabetes Assoc. 107:119–125. 1999.PubMed/NCBI View Article : Google Scholar : [and].
12	Galic S, Oakhill JS and Steinberg GR: Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 316:129–139. 2010.PubMed/NCBI View Article : Google Scholar
13	Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin H-M, Kales A and Chrousos GP: Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 85:1151–1158. 2000.PubMed/NCBI View Article : Google Scholar
14	Liu H, Liu J, Xiong S, Shen G, Zhang Z and Xu Y: The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ. 20:200–202. 2000.PubMed/NCBI View Article : Google Scholar
15	Mohamad HE, Asker ME, Keshawy MM, Abdel Aal SM and Mahmoud YK: Infliximab ameliorates tumor necrosis factor-alpha exacerbated renal insulin resistance induced in rats by regulating insulin signaling pathway. Eur J Pharmacol. 872(172959)2020.PubMed/NCBI View Article : Google Scholar
16	Chen FC, Shen KP, Ke LY, Lin HL, Wu CC and Shaw SY: Flavonoids from Camellia sinensis (L.) O. Kuntze seed ameliorates TNF-α induced insulin resistance in HepG2 cells. Saudi Pharm J. 27:507–516. 2019.PubMed/NCBI View Article : Google Scholar
17	Scheidereit C: IkappaB kinase complexes: Gateways to NF-kappaB activation and transcription. Oncogene. 25:6685–6705. 2006.PubMed/NCBI View Article : Google Scholar
18	Karin M: How NF-kappaB is activated: The role of the IkappaB kinase (IKK) complex. Oncogene. 18:6867–6874. 1999.PubMed/NCBI View Article : Google Scholar
19	Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A and Ben-Neriah Y: I A. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA. 92:10599–10603. 1995.PubMed/NCBI View Article : Google Scholar
20	Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J and Shoelson SE: Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 11:183–190. 2005.PubMed/NCBI View Article : Google Scholar
21	Huang H and Huang H: Diagnosis of obstructive sleep apnea hypopnea syndrome in children. Health Care (Don Mills). 20:108–109. 2020.
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
23	Bixler EO, Vgontzas AN, Lin H-M, Liao D, Calhoun S, Vela-Bueno A, Fedok F, Vlasic V and Graff G: Sleep disordered breathing in children in a general population sample: Prevalence and risk factors. Sleep. 32:731–736. 2009.PubMed/NCBI View Article : Google Scholar
24	Guilleminault C and Pelayo R: Sleep-disordered breathing in children. Ann Med. 30:350–356. 1998.PubMed/NCBI View Article : Google Scholar
25	Enright PL, Goodwin JL, Sherrill DL, Quan JR and Quan SF: Tucson Children's Assessment of Sleep Apnea study. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: The Tucson Children's Assessment of Sleep Apnea study. Arch Pediatr Adolesc Med. 157:901–904. 2003.PubMed/NCBI View Article : Google Scholar
26	Kohyama J, Ohinata JS and Hasegawa T: Blood pressure in sleep disordered breathing. Arch Dis Child. 88:139–142. 2003.PubMed/NCBI View Article : Google Scholar
27	Leung LC, Ng DK, Lau MW, Chan CH, Kwok KL, Chow PY and Cheung JM: Twenty-four-hour ambulatory BP in snoring children with obstructive sleep apnea syndrome. Chest. 130:1009–1017. 2006.PubMed/NCBI View Article : Google Scholar
28	Li AM, Au C-T, Sung RY, Ho C, Ng PC, Fok TF and Wing YK: Ambulatory blood pressure in children with obstructive sleep apnoea: A community based study. Thorax. 63:803–809. 2008.PubMed/NCBI View Article : Google Scholar
29	Marcus CL, Greene MG and Carroll JL: Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med. 157:1098–1103. 1998.PubMed/NCBI View Article : Google Scholar
30	Sateia MJ: International classification of sleep disorders-third edition: Highlights and modifications. Chest. 146:1387–1394. 2014.PubMed/NCBI View Article : Google Scholar
31	Sun SS, Grave GD, Siervogel RM, Pickoff AA, Arslanian SS and Daniels SR: Systolic blood pressure in childhood predicts hypertension and metabolic syndrome later in life. Pediatrics. 119:237–246. 2007.PubMed/NCBI View Article : Google Scholar
32	Du J, Gu C and Li M: Research progress in the relationship between obstructive sleep apnea-hypopnea syndrome and insulin resistance International Journal of. Respiration. 33:1503–1506. 2013.
33	Sarac F, Basoglu OK, Gunduz C, Bayrak H, Biray Avci C and Akcicek F: Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome. J Endocrinol Invest. 34:528–533. 2011.PubMed/NCBI View Article : Google Scholar
34	Wang H, Li J, Gai Z, Kullak-Ublick GA and Liu Z: TNF-α deficiency prevents renal inflammation and oxidative stress in obese mice. Kidney Blood Press Res. 42:416–427. 2017.PubMed/NCBI View Article : Google Scholar
35	Davizon-Castillo P, McMahon B, Aguila S, Bark D, Ashworth K, Allawzi A, Campbell RA, Montenont E, Nemkov T, D'Alessandro A, et al: TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. Blood. 134:727–740. 2019.PubMed/NCBI View Article : Google Scholar
36	Camacho M, Certal V, Abdullatif J, Zaghi S, Ruoff CM, Capasso R and Kushida CA: M C: V C, J A, S Z, CM R, R C and CA K. Myofunctional therapy to treat obstructive sleep apnea: A systematic review and meta-analysis. Sleep (Basel). 38:669–675. 2015.PubMed/NCBI View Article : Google Scholar
37	Khalyfa A, Serpero LD, Kheirandish-Gozal L, Capdevila OS and Gozal D: TNF-α gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr. 158:77–82. 2011.PubMed/NCBI View Article : Google Scholar
38	Ming H, Tian A, Liu B, Hu Y, Liu C, Chen R and Cheng L: Inflammatory cytokines tumor necrosis factor-α, interleukin-8 and sleep monitoring in patients with obstructive sleep apnea syndrome. Exp Ther Med. 17:1766–1770. 2019.PubMed/NCBI View Article : Google Scholar
39	Shoelson SE, Lee J and Yuan M: Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance. Int J Obes Relat Metab Disord. 27 (Suppl 3):S49–S52. 2003.PubMed/NCBI View Article : Google Scholar
40	Benzler J, Ganjam GK, Pretz D, Oelkrug R, Koch CE, Legler K, Stöhr S, Culmsee C, Williams LM and Tups A: Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes. 64:2015–2027. 2015.PubMed/NCBI View Article : Google Scholar
41	Jové M, Planavila A, Sánchez RM, Merlos M, Laguna JC and Vázquez-Carrera M: Palmitate induces tumor necrosis factor-alpha expression in C2C12 skeletal muscle cells by a mechanism involving protein kinase C and nuclear factor-kappaB activation. Endocrinology. 147:552–561. 2006.PubMed/NCBI View Article : Google Scholar
42	de Alvaro C, Teruel T, Hernandez R and Lorenzo M: Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem. 279:17070–17078. 2004.PubMed/NCBI View Article : Google Scholar
43	Mireia J, Anna P, Carlos LJ and Manuel Vz-C: Palmitate-induced interleukin 6 production is mediated by protein kinase c and nuclear-factor κB activation and leads to glucose transporter 4 down-regulation in skeletal muscle cells. Endocrinology. 146:3087–3095. 2005.PubMed/NCBI View Article : Google Scholar
44	Czech MP: Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 23:804–814. 2017.PubMed/NCBI View Article : Google Scholar
45	Makki K, Froguel P and Wolowczuk I: Adipose tissue in obesity-related inflammation and insulin resistance: Cells, cytokines, and chemokines. ISRN Inflamm. 2013(139239)2013.PubMed/NCBI View Article : Google Scholar
46	Ji C, Chen X, Gao C, Jiao L, Wang J, Xu G, Fu H, Guo X and Zhao Y: IL-6 induces lipolysis and mitochondrial dysfunction, but does not affect insulin-mediated glucose transport in 3T3-L1 adipocytes. J Bioenerg Biomembr. 43:367–375. 2011.PubMed/NCBI View Article : Google Scholar